These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32419122)

  • 1. An NMR Protocol for In Vitro Paclitaxel Release from an Albumin-Bound Nanoparticle Formulation.
    Suh MS; Patil SM; Kozak D; Pang E; Choi S; Jiang X; Rodriguez JD; Keire DA; Chen K
    AAPS PharmSciTech; 2020 May; 21(5):136. PubMed ID: 32419122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel.
    Stinchcombe TE
    Nanomedicine (Lond); 2007 Aug; 2(4):415-23. PubMed ID: 17716129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges of nanoparticle albumin bound (nab™) technology: Comparative study of Abraxane® with a newly developed albumin-stabilized itraconazole nanosuspension.
    Adick A; Hoheisel W; Schneid S; Mulac D; Azhdari S; Langer K
    Eur J Pharm Biopharm; 2023 Dec; 193():129-143. PubMed ID: 37918678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing in Vitro Release Kinetics of Long-Acting Injectable Nanosuspensions via Flow-NMR Spectroscopy.
    Rudd ND; Helmy R; Dormer PG; Williamson RT; Wuelfing WP; Walsh PL; Reibarkh M; Forrest WP
    Mol Pharm; 2020 Feb; 17(2):530-540. PubMed ID: 31895571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug.
    Battogtokh G; Kang JH; Ko YT
    Eur J Pharm Biopharm; 2015 Oct; 96():96-105. PubMed ID: 26212785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.
    Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
    Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Carrier-Oriented Polygeline for Preparing Novel Polygeline-Bound Paclitaxel Nanoparticles.
    Xiong K; Wu J; Liu Y; Wu N; Ruan J
    J Pharm Sci; 2019 Jun; 108(6):2012-2021. PubMed ID: 30639741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous?
    Li C; Li Y; Gao Y; Wei N; Zhao X; Wang C; Li Y; Xiu X; Cui J
    Int J Pharm; 2014 Jul; 468(1-2):15-25. PubMed ID: 24709221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
    Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA
    Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation and drug release property of paclitaxel nanoparticles].
    Wang TW; Wu Y; Li MJ; Gao HX
    Zhong Yao Cai; 2009 Sep; 32(9):1447-9. PubMed ID: 20034226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scanning Electron-Raman Cryomicroscopy for Characterization of Nanoparticle-Albumin Drug Products.
    Yilmaz H; Ahmed S; Rodriguez JD; Willett DR
    Anal Chem; 2023 Feb; 95(5):2633-2638. PubMed ID: 36693238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and physicochemical characterization of a novel paclitaxel-loaded amphiphilic aminocalixarene nanoparticle platform for anticancer chemotherapy.
    Weeden C; Hartlieb KJ; Lim LY
    J Pharm Pharmacol; 2012 Oct; 64(10):1403-11. PubMed ID: 22943171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategic Pentablock Copolymer Nanomicellar Formulation for Paclitaxel Delivery System.
    Owiti AO; Mitra A; Joseph M; Pal D
    AAPS PharmSciTech; 2018 Oct; 19(7):3110-3122. PubMed ID: 30112614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible exposure of hydrophobic residues on albumin as a novel strategy for formulation of nanodelivery vehicles for taxanes.
    Garro AG; Beltramo DM; Alasino RV; Leonhard V; Heredia V; Bianco ID
    Int J Nanomedicine; 2011; 6():1193-200. PubMed ID: 21822381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An organic solvent-free technology for the fabrication of albumin-based paclitaxel nanoparticles for effective cancer therapy.
    Zhao Y; Cai C; Liu M; Zhao Y; Pei W; Chu X; Zhang H; Wang Z; Han J
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110394. PubMed ID: 31398618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nontoxic disulfide bond reducing method for lipophilic drug-loaded albumin nanoparticle preparation: formation dynamics, influencing factors and formation mechanisms investigation.
    Jiang L; Xu Y; Liu Q; Tang Y; Ge L; Zheng C; Zhu J; Liu J
    Int J Pharm; 2013 Feb; 443(1-2):80-6. PubMed ID: 23291446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting.
    Bansal A; Kapoor DN; Kapil R; Chhabra N; Dhawan S
    Acta Pharm; 2011 Jun; 61(2):141-56. PubMed ID: 21684843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocopheryl succinate-based lipid nanospheres for paclitaxel delivery: preparation, characters, and in vitro release kinetics.
    Shi K; Jiang Y; Zhang M; Wang Y; Cui F
    Drug Deliv; 2010 Jan; 17(1):1-10. PubMed ID: 19941405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer.
    Guarneri V; Dieci MV; Conte P
    Expert Opin Pharmacother; 2012 Feb; 13(3):395-406. PubMed ID: 22263900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.